Case Study: Top-10 Global Pharmaceutical Company achieves a 6‑week earlier FPI by removing eCOA from the critical path with Medable eCOA+

Medable beats forecasted FPI date by taking eCOA off the critical path

The Top-10 Global Pharmaceutical Company partnered with Medable to standardize and scale weight management trials run under a master protocol with multiple sub‑studies across 70+ research sites. Concerned about participant and site experience—particularly enrollment and study startup timelines since participants must enroll via the master protocol before entering sub‑studies—the sponsor engaged Medable to deploy eCOA+, the Medable platform, and provisioned devices.

Medable implemented optimized workflows, live site and participant training, and a flexible, standardized technology package; critically, Medable’s eCOA+ removed eCOA from the critical path and enabled deployment in just six weeks. As a result, the partner beat forecasted FPI milestones (6 weeks ahead of schedule), achieved 90%+ adherence, standardized the site and patient experience, and improved ROI.